Immunization with specific polysaccharide antigen reduces alterations in corneal proteoglycans during experimental

C D Georgakopoulos1, A M Exarchou, S P Gartaganis

  • 1Department of Ophthalmology, School of Medicine, University of Patras, Greece, and Department of Laboratory Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.

Current Eye Research
|February 28, 2006
PubMed
Abstract

Insights

Active and passive immunization against Staphylococcus epidermidis slime (20-kDa PS) reduced corneal lesions and altered proteoglycan distribution in experimental keratitis. This suggests the 20-kDa PS and its antibodies are promising agents for treating bacterial keratitis.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Immunology

Background:

  • Staphylococcus epidermidis is a primary cause of bacterial keratitis, leading to significant corneal damage.
  • Corneal integrity relies on matrix macromolecules like proteoglycans (PGs) and collagen.
  • Slime-producing S. epidermidis strains pose a particular challenge in treating keratitis.

Purpose of the Study:

  • To investigate the effects of active immunization (AI) and passive immunization (PI) using the 20-kDa polysaccharide (PS) of S. epidermidis slime on corneal lesions.
  • To examine the impact of AI and PI on proteoglycan distribution during the healing of experimental keratitis.
  • To assess the role of antibodies against the 20-kDa PS in managing S. epidermidis-induced keratitis.

Main Methods:

  • Rabbits underwent AI with 20-kDa PS or PI with anti-20-kDa PS antibodies.
  • Corneal lesions were clinically graded over 21 days.
  • Antibody levels were measured by ELISA, and PG distribution was analyzed immunohistochemically.

Main Results:

  • Both AI and PI groups showed significantly higher levels of specific antibodies in serum and aqueous humor compared to controls.
  • Immunized rabbits exhibited significantly reduced corneal damage compared to non-treated infected rabbits.
  • PG accumulation (keratan sulfate, decorin, heparan sulfate) in corneal stroma and around new vessels was significantly reduced in immunized animals.

Conclusions:

  • The 20-kDa PS and its specific antibodies demonstrate significant prophylactic and therapeutic potential.
  • These findings highlight the crucial role of the 20-kDa PS in S. epidermidis keratitis pathogenesis and immune response.
  • Targeting the 20-kDa PS offers a promising strategy for developing new treatments for bacterial keratitis.

Related Concept Videos